NCT07127289View on ClinicalTrials.gov

Autologous Hematopoietic Stem Cell Infusion for Prolonged Cytopenia After CAR-T Cell Therapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2028

Conditions
Prolonged Cytopenia Following CAR-T Therapy
Interventions
BIOLOGICAL

Autologous hematopoietic stem cell infusion

Autologous hematopoietic stem cell infusion (0.5-3.0×10\^6/kg)

Trial Locations (1)

Unknown

RECRUITING

Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin

All Listed Sponsors
lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER

NCT07127289 - Autologous Hematopoietic Stem Cell Infusion for Prolonged Cytopenia After CAR-T Cell Therapy | Biotech Hunter | Biotech Hunter